Pharming Group N.V. OverviewPharming Group N.V. Other Income Expense Net
Other Income/Expense Net for PHAR.
Quarterly Other Income/Expense
-$7.29M
↓ 53.72% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$12.03M
↓ 549.05% YoY
Trailing 12 months ending Mar 31, 2026